Evidence map›Paper›PMID 37485260›Full record

ArticleFrontiers in cardiovascular medicine2023

Predicting the risk of iliofemoral vascular complication in complex transfemoral-TAVR using new generation transcatheter devices.

Ofir Koren, Vivek Patel, Yuval Tamir, Keita Koseki, Danon Kaewkes, Troy Sanders, Robert Naami, Edmund Naami, Daniel Eugene Cheng, Sharon Shalom Natanzon and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. VARC-HBR criteria validation in TAVI patients on oral anticoagulation.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 4 countries.

Ofir KorenCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Vivek PatelCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Yuval TamirWeizmann Institute of Science, Rehovot, Israel.
Keita KosekiCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Danon KaewkesQueen Sirikit Heart Center of the Northeast, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Troy SandersDavid Geffen School of Medicine, University of California (UCLA), Los Angeles, California.
Robert NaamiInternal Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve, University School of Medicine, Cleveland, United States.
Edmund NaamiSchool of Medicine, University of Illinois, Chicago, IL, United States.
Daniel Eugene ChengCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Sharon Shalom NatanzonCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Alon ShechterCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Jeffrey GornbeinDavid Geffen School of Medicine, University of California (UCLA), Los Angeles, California.
Tarun ChakravartyCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Mamoo NakamuraCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Wen ChengCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Hasan JilaihawiCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Raj R MakkarCedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California.
Cedars-Sinai Medical Center · USCedars-Sinai Smidt Heart Institute · USUniversity of California, Los Angeles · USKhon Kaen University · THUniversity of Illinois Chicago · USUniversity School · USWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Design a predictive risk model for minimizing iliofemoral vascular complications (IVC) in a contemporary era of transfemoral-transcatheter aortic valve replacement (TF-TAVR). Background: IVC remains a common complication of TF-TAVR despite the technological improvement in the new-generation transcatheter systems (NGTS) and enclosed poor outcomes and quality of life. Currently, there is no accepted tool to assess the IVC risk for calcified and tortuous vessels. Methods: We reconstructed CT images of 516 propensity-matched TF-TAVR patients using the NGTS to design a predictive anatomical model for IVC and validated it on a new cohort of 609 patients. Age, sex, peripheral artery disease, valve size, and type were used to balance the matched cohort. Results: IVC occurred in 214 (7.2%) patients. Sheath size ( Conclusion: Our CT-based validated-model is the most accurate and easy-to-use tool assessing IVC risk and should be used for calcified and tortuous vessels in preprocedural planning.

Indexed as

aortic stenosiscalcificationcrossabilityiliofemoral vascular complicationsrisk modelTAVRtortuosityvalidation & verification component

Identifiers

PMID37485260
PMCPMC10357287
OpenAlexW4383343641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.